含有素的黑色素纳米颗粒用于长期的无感选择性神经阻塞
Xiaosi Li1, Qi Li1, Xinyu Xia2
1Department of Chemical and Biological Engineering, University of Alabama, Tuscaloosa, Alabama 35487, United States.
Langmuir : the ACS journal of surfaces and colloids
|November 14, 2024
概括
研究人员开发了含有素的黑色素纳米粒子 (Cap-MNPs),以改善疼痛缓解. 这些纳米粒子提供了更持久的,选择性神经阻塞,没有运动功能损失或毒性.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术 纳米技术
- 药理学 药理学是指药理学的学科.
背景情况:
- 目前的局部麻醉剂如布皮瓦卡因和利多卡因的持续时间有限,影响感觉神经元和运动神经元,导致不必要的运动功能丧失.
- 开发新的药物输送系统对于治疗疼痛的有针对性和持续的治疗效果至关重要.
研究的目的:
- 设计含有素的黑色素纳米粒子 (Cap-MNPs),以克服传统局部麻醉药的局限性.
- 为了实现选择性的感觉神经阻塞,具有延长的作用时间和最小的毒性.
主要方法:
- 封装素在黑色素纳米颗粒 (MNP) 中使用疏水和π-π相互作用.
- 对药物加载效率,容量和体外释放动力学的Cap-MNP的表征.
- 在老鼠坐骨神经阻塞模型中评估Cap-MNP的疗效,持续时间和毒性.
主要成果:
- 卡普-MNP表现出高的药物负载效率 (82.99 ± 1.55%) 和容量 (67.47 ± 4.24%).
- 从Cap-MNPs中持续释放的素超过了360小时.
- 在老鼠中,一次注射Cap-MNPs产生了长达6小时的 sciatic感觉神经阻塞,没有局部或全身毒性.
结论:
- 含有素的黑色素纳米粒子 (Cap-MNPs) 为选择性和长效的感觉神经阻塞提供了一个有希望的策略.
- 卡普-MNP为有效的疼痛管理提供了潜在的治疗进步,并减少了副作用.
相关概念视频
01:24Local Anesthetics: Differential Sensitivity of Nerve Fibers
776
Local anesthetics (LAs) block the sodium channels of nerve trunks, sensory nerve endings, and neuromuscular junctions. Although LAs can block all kinds of nerves, the sensitivity of nerve fibers differs according to nerve types and structures. LAs are known to block myelinated fibers faster than unmyelinated ones. Also, they block pain or sensory neurons at low concentrations without affecting the motor neurons involved in muscle contractions. This helps relieve labor pain without affecting the...
776
01:44Nociception
27.7K
Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain.
27.7K
01:30Local Anesthetics: Clinical Application as Surface, Infiltration, and Conduction Block Anesthesia
976
Depending on the target organ, local anesthetics (LAs) can be administered via various routes. In surface anesthesia, LAs are applied directly to the surface of the skin or mucous membranes. It is widely used for topical skin numbing before venipuncture or minor surgical procedures. Commonly used surface local anesthetics are lidocaine or benzocaine sprays or creams. Surface anesthesia occurs within 5 minutes and lasts for about 60 minutes. One of the main disadvantages of topical anesthesia is...
976
01:23Local Anesthetics: Mechanism of Action
2.2K
Local anesthetics (LAs) block sensory and motor impulses by inhibiting the sodium channels on the nerve cell membranes. This induces temporary loss of sensation, relieving pain in a specific body area.
Local anesthetics are amphiphilic molecules consisting of a hydrophobic aromatic part linked to a hydrophilic group by an ester or amide linkage. They are weak bases and are usually available as salts, which increases their solubility and stability. Once administered, LAs exist in the body either...
Local anesthetics are amphiphilic molecules consisting of a hydrophobic aromatic part linked to a hydrophilic group by an ester or amide linkage. They are weak bases and are usually available as salts, which increases their solubility and stability. Once administered, LAs exist in the body either...
2.2K
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
148
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
148
01:25Analgesia and Pain Management
518
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
518